
Novo Nordisk (NVO) Earnings Dates & Reports
Novo Nordisk (NVO) Most Recent Earnings
Report DateMay 7, 2025
Period EndingQ1 2025
Est. EPS$0.90
Actual EPS$0.92
EarningsBeat
Novo Nordisk (NVO) Earnings
View the latest Novo Nordisk (NVO) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Novo Nordisk (NVO)
Order type
Buy in
Order amount
Est. shares
0 shares
Novo Nordisk (NVO) Earnings per Share (EPS) History
Signup for full accessBrowse free
Novo Nordisk (NVO) Latest Earnings
The value each NVO share was expected to gain vs. the value each share gained.
Novo Nordisk (NVO) reported its most recent earnings on May 7, 2025 for Q1 2025, posting earnings per share (EPS) of $0.92. This exceeded analysts' expectations of $0.90 by 2.22%, marking a Beat.
For comparison, Novo Nordisk reported EPS of $0.83 in the same quarter last year.
The company is expected to announce its next earnings report on 08/06/2025, with analysts projecting an EPS of $0.89.
Novo Nordisk (NVO) Earnings History
Novo Nordisk (NVO) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Novo Nordisk’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 7, 2025 | — | — | — |
Feb 5, 2025 | — | — | — |
Nov 6, 2024 | — | — | — |
Aug 7, 2024 | — | — | — |
Novo Nordisk (NVO) Earnings FAQs
Novo Nordisk (NVO) last reported earnings on May 7, 2025 for Q1 2025, posting an EPS of $0.92, which Beat the estimate of $0.90 by 2.22%.
For Q1 2025, Novo Nordisk (NVO) reported an EPS of $0.92, exceeding analysts' estimate of $0.90 by 2.22%.
For Q1 2025, Novo Nordisk (NVO) Beat expectations with an actual EPS of $0.92 vs. an estimated EPS of $0.90.
Following the last earnings report on May 7, 2025, Novo Nordisk (NVO)'s stock price moved — from — to —.
The next Novo Nordisk (NVO) earnings call is scheduled for Aug. 6, 2025, where executives will discuss financial results and outlook.